Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
AAPS PharmSciTech ; 24(1): 40, 2023 Jan 18.
Article in English | MEDLINE | ID: mdl-36653508

ABSTRACT

Aminexil (AMX) is considered to be one of the most widely used hair growth promoters. Nanostructured lipid carriers (NLC) are employed to increase the permeation of both lipophilic and hydrophilic drugs. Aminexil nanostructured lipid carrier (NLC) designed by pre-emulsion/ultrasonication method was utilized for alopecia treatment. For selecting optimum excipients, a solubility study was executed in liquid lipids, solid lipids, surfactants, and co-surfactants. A 23 full factorial design was utilized for NLC optimization. Characterization of the developed formulas was performed. The penetration of the optimized formula across cuticle tissues was studied using confocal laser scanning microscopy (CLSM). AMX showed high solubility in glyceryl monostearate (GMS) and stearic acid, 28.87 ± 2.17 and 58.06 ± 2.227 mg/g, respectively. The results of physicochemical characterization showed that formula A7 was the optimized one. It is composed of GMS (solid lipid), oleic acid:garlic oil (1:1 v/v) (liquid lipid), and a surfactant/co-surfactant mixture (Cremophor EL/Transcutol HP). The particle size (PS) was 238.0 ± 2.13 nm, entrapment efficiency (EE) 100.535 ± 6.73%, and zeta potential (ZP) - 29.3 ± 0.93 mv. Ex vivo permeation study demonstrates the potential of AMX-NLC (formula A7) as a delivery system for AMX. The CLSM highly proved AMX-loaded NLC penetration through the skin. The histological study clearly demonstrated that AMX-loaded NLC promoted hair growth more effectively than the market product in chemotherapy-induced alopecia rats. The acquired findings revealed that targeting of AMX-loaded NLC into hair follicles was improved.


Subject(s)
Nanoparticles , Nanostructures , Rats , Animals , Drug Carriers/chemistry , Lipids/chemistry , Skin , Nanostructures/chemistry , Alopecia/chemically induced , Alopecia/drug therapy , Particle Size , Nanoparticles/chemistry
2.
J Food Sci ; 86(10): 4444-4456, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34431103

ABSTRACT

To guarantee food safetyand sustainability, it is necessary to verify meat authenticity. This study focused on the development of single nucleotide polymorphism-based polymerase chain reaction-restriction fragment length polymorphism (SNP-based PCR-RFLP) and forensically informative nucleotide sequence (FINS) methodologies based on PCR amplification of the mitochondrial 12S rRNA gene for discrimination of six red meat species, that is, cattle, buffalo, goat, sheep, camel, and donkey. FINS allowed the unambiguous identification of all species analyzed. In addition, six SNPs, where a restriction site for TasI could be localized using a preliminary in silico analysis, gave a unique RFLP pattern for each species. The results revealed a low level of species substitution (8%) in the tested meat samples. In particular, one buffalo and goat samples have been substituted with cow and sheep, respectively. Finally, the developed techniques herein showed high potentials to be routinely used as reliable and fast tools to avoid meat species substitutions. PRACTICAL APPLICATION: This research deals with genetic techniques to trace meats. This kind of research helps the concerned agencies to build capacity to safeguard consumer sentiments as well as providing better market access and better food price and quality for the consumer.


Subject(s)
Food Technology , Meat , Polymorphism, Single Nucleotide , Animals , Camelus/genetics , Cattle/genetics , Equidae/genetics , Food Technology/methods , Goats/genetics , Meat/analysis , Meat/classification , Polymorphism, Restriction Fragment Length , Sheep/genetics , Species Specificity
3.
Drug Dev Ind Pharm ; 44(2): 316-328, 2018 Feb.
Article in English | MEDLINE | ID: mdl-29096550

ABSTRACT

Coenzyme Q10 (CoQ10) is an insoluble, poorly permeable antioxidant with great biological value which acts as anti-aging and anti-wrinkle agent. To improve its permeability through topical application, the current study aimed at formulating oil/water (o/w) nanoemulsion (NE) as an efficient vehicle for delivering (CoQ10) through the skin barriers. The solubility of (CoQ10) was tested for various oils, surfactants (S), and co-surfactants (CoS). The NE region was determined by constructing pseudoternary phase diagrams. NE formulae containing 1, 2, and 3% w/w drug have been subjected to thermodynamic stability test. The formulae that passed thermodynamic stability tests were characterized by physical properties as pH, viscosity, refractive index, droplet size, zeta-potential, TEM, electroconductivity, in vitro release, and ex vivo permeation. The formula 'F2' containing 10% w/w isopropyl myristate (oil phase), 60% w/w of Tween 80: Transcutol HP mixture (S/CoSmix) at ratio 2:1, 30% w/w water and 2% w/w drug was evaluated for its anti-wrinkle efficiency using an animal model. The 'F2' formula showed 11.76 ± 1.1 nm droplet size, 1.4260 ± 0.0016 refractive index, 0.228 PDI, -14.7 ± 1.23 mv zeta potential, 7.06 ± 0.051 pH, 199.05 ± 0.35 cp viscosity, and the highest percentage of drug release in the selected dissolution media. About 47.21% of the drug was released in phosphate buffer 7.4 containing 5% w/v Labrasol and 5% w/v isopropyl alcohol through 24 h. It also showed the highest drug flux (Jss = 3.164 µg/cm2/h), enhancement ratio (Er = 8.32), and permeability coefficient (Kp = 22.14 × 10-4 cm2/h). CoQ10 NE reduced the skin wrinkles and gave the skin smooth appearance. Our investigation suggests the potential use of NE as a vehicle for enhancing solubility and permeability of CoQ10 and thus improving its anti-wrinkle efficiency.


Subject(s)
Emulsions/chemistry , Nanoparticles/chemistry , Skin Absorption/physiology , Skin Aging/drug effects , Ubiquinone/analogs & derivatives , Administration, Cutaneous , Animals , Chemistry, Pharmaceutical , Drug Delivery Systems , Drug Liberation , Drug Stability , Female , Hydrogen-Ion Concentration , Particle Size , Rats , Rats, Wistar , Solubility , Surface Properties , Surface-Active Agents/chemistry , Ubiquinone/administration & dosage , Ubiquinone/pharmacology , Viscosity
4.
Egypt J Immunol ; 24(2): 9-22, 2017 Jun.
Article in English | MEDLINE | ID: mdl-29528575

ABSTRACT

Atopic dermatitis (AD) is a worldwide chronic inflammation of skin.Many factors and chemokines play role in pathogenesis of AD. Identifying the reliable biomarkers to diagnose and assess severity of AD is important. In this study we aimed to find a reliable biomarker to determine the severity of AD and monitor treatment as well as, examining the possible association between IL-18 gene [rs 187238] promoter polymorphism and AD disease. The study included 30 Egyptian patients with AD and 30 healthy controls. Patients were clinically evaluated according to SCORAD scoring system. For each subject levels of Thymus and activation regulated chemokine (TARC), IL-18, total IgE and Lactate dehydrogenase enzyme (LDH) in serum were measured and Polymorphism in IL-18 gene was analyzed using restriction fragment length polymorphism (RFLP). Patients were reevaluated after treatment. Serum levels of TARC, IL-18, IgE and LDH were significantly higher in patients than controls, and were associated with high SCORAD score. G allele was risk factor with OR 2.31 (1.10- 4.85) and significant p-value < 0.05 for AD. GG genotype was significantly associated with elevated serum levels of TARC, IL-18 and IgE. After treatment serum level of TARC showed significant decrease and was associated with low SCORAD score. We concluded that TARC, IL-18, total IgE and LDH are potential markers of severity in AD. G allele in IL-18 gene [rs 187238] is risk factor for AD while C allele is considered protective. TARC is also a reliable marker formonitoring treatment.


Subject(s)
Chemokine CCL17/blood , Dermatitis, Atopic/genetics , Interleukin-18/blood , Interleukin-18/genetics , Biomarkers/blood , Dermatitis, Atopic/blood , Egypt , Humans , Immunoglobulin E/blood , L-Lactate Dehydrogenase/blood , Risk Factors , Severity of Illness Index
SELECTION OF CITATIONS
SEARCH DETAIL
...